SecBot SecBot
144 ·Filed Aug 10, 2026

PTGX

Protagonist Therapeutics, Inc
BEARISH
Impact 5/10
Horizonimmediate Processed3mo ago SEC0001968582-26-000805
Form 144, notice of proposed sale of securities
Actionable Insight ▼ Bearish

CEO's large proposed sale (~$33.6M) signals potential insider distribution; monitor for actual Form 4 filings to confirm execution. The sale is concurrent with option exercise, suggesting a planned liquidity event rather than a distress signal, but the magnitude relative to market cap is notable. Watch for any subsequent insider selling patterns or changes in guidance.

DirectionBearish
Confidencemedium
Horizonimmediate

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$148.29
T+0 close · Aug 10, 2026 · via day close
Latest settled
−3.32%
T+60 · $143.37
Vs SPY
−2.83%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 11 $148.29entry
  2. T+1 · 3mo ago +2.51%α +2.26% · $152.01
  3. T+5 · 3mo ago +6.10%α +6.51% · $157.34
  4. T+20 · 2mo ago −2.16%α −1.10% · $145.09
  5. T+60 · 13d ago −3.32%α −2.83% · $143.37
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Dinesh Patel filed a Form 144 notice of intent to sell 225,000 shares of Protagonist Therapeutics (PTGX) through J.P. Morgan Securities, with an estimated aggregate market value of approximately $33.6 million based on the filing date. This represents a large proposed sale relative to Patel's remaining holdings of ~64.7 million shares, but the CEO's intent to sell a meaningful stake signals potential insider distribution at a $9.4B market cap company.

Key Facts

  • CEO Dinesh Patel filed Form 144 to sell 225,000 shares of PTGX common stock.
  • Estimated aggregate market value of the proposed sale is $33,583,500.
  • Patel holds approximately 64,708,285 shares after the proposed sale (post-sale holdings).
  • The shares to be sold were acquired via option exercise on August 10, 2026.
  • The sale is planned through J.P. Morgan Securities LLC as agent.
  • The filing date is August 10, 2026; the proposed sale date is also August 10, 2026.

Financial Impact

CEO proposes to sell ~$33.6M worth of stock, representing ~0.35% of market cap and ~0.35% of his post-sale holdings.

insider holdingsdilutionmarket cap

Risk Factors

  • CEO selling a large dollar amount could signal lack of confidence or need for liquidity.
  • The sale may be executed quickly (same-day filing and proposed sale date), increasing near-term selling pressure.
  • If the sale is completed, it could weigh on sentiment given the $9.4B market cap and 90% analyst bullishness.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001968582-26-000805
Document: 0001968582-26-000805-index.html0001968582-26-000805
Document: 0001968582-26-000805.txt0001968582-26-000805

Track record

11 reports on PTGX

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 5, 202611d ago 8-K Bullish 7/10 Entry $132.04 Now $124.83 −5.46% settles Feb 4
  2. Nov 4, 202612d ago Institutional Cluster Mixed 3/10 Entry $143.37 Now $124.83 −12.93% settles Feb 2
  3. Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $142.14 Now $124.83 −12.18% settles Jan 26
  4. Aug 10, 202614w ago 144 Bearish 5/10 Viewing Entry $148.29 to $143.37 Now $124.83 +15.82% ▲ +3.32% +2.83% vs SPY
  5. Jun 18, 202621w ago 8-K Neutral 3/10 Entry $115.03 to $143.40 Now $124.83 +8.52% ▲ +24.66% +22.92% vs SPY
  6. Jun 12, 202622w ago Institutional Cluster Mixed 5/10 Entry $109.78 to $145.94 Now $124.83 +13.71% ▲ +32.94% +29.67% vs SPY
  7. May 12, 202626w ago 144 Bearish 5/10 Entry $103.88 to $145.87 Now $124.83 −20.17% ▼ −40.42% −35.98% vs SPY
  8. May 8, 202627w ago Insider Cluster Neutral 4/10 Entry $99.36 to $135.81 Now $124.83 +25.63% ▲ +36.68% +31.85% vs SPY
  9. May 8, 202627w ago Insider Cluster Neutral 5/10 Entry $99.36 to $135.81 Now $124.83 +25.63% ▲ +36.68% +31.85% vs SPY
  10. May 5, 202627w ago 8-K Bullish 7/10 Entry $103.97 to $136.64 Now $124.83 +20.06% ▲ +31.42% +29.36% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens in 6h 35m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 10, 2026